Skip to main content

Table 3 Adiponectin as a risk factor of metabolic syndrome

From: Hypoadiponectinemia and the presence of metabolic syndrome in patients with chronic kidney disease: results from the KNOW-CKD study

 

Odds ratio (95% confidence interval)

Total

P

Crude

0.966 (0.954–0.978)

<0.001

Model 1

0.983 (0.969–0.997)

0.015

Model 2

0.961 (0.946–0.977)

<0.001

Model 3

0.959 (0.940–0.979)

<0.001

Model 4

0.956 (0.937–0.976)

<0.001

  1. Adiponectin 1 μg/mL increase, subgroup analysis was performed according to the cause of chronic kidney disease
  2. Model 1: adjusted for age, sex, smoking status, and body mass index
  3. Model 2: adjusted for model 1 + hemoglobin, serum albumin, uric acid, and phosphate
  4. Model 3: adjusted for model 2 + hs-CRP, urinary albumin-to-creatinine ratio, and eGFR
  5. Model 4: adjusted for model 3 + coronary artery disease, cerebrovascular disease, ARB, diuretics, statin, ezetimibe, and fibrate
  6. DM diabetes mellitus, hs-CRP high sensitivity C-reactive protein, eGFR estimated glomerular filtration rate, ARB angiotensin II receptor blocker
Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us